A fetal oncogene NUAK2 is an emerging therapeutic target in glioblastoma
Hanhee Jo(University of California San Diego), Stacey M. Glasgow(University of California San Diego)
Cited by 2
Related Papers
Glia-specific enhancers and chromatin structure regulate NFIA expression and glioma tumorigenesis
|Nature Neuroscience|2017|58
The critical role of glucose deprivation in epithelial-mesenchymal transition in hepatocellular carcinoma under hypoxia
|Scientific Reports|2020|31
Modulation of SIRT3 expression through CDK4/6 enhances the anti-cancer effect of sorafenib in hepatocellular carcinoma cells
|BMC Cancer|2020|30